10-Q 1 gco-20230729.htm 10-Q 10-Q
--02-03falseQ2000001849820240000018498us-gaap:AdditionalPaidInCapitalMember2022-01-290000018498us-gaap:CorporateNonSegmentMember2022-05-012022-07-300000018498us-gaap:RetainedEarningsMember2022-01-302022-04-300000018498us-gaap:TrademarksMember2023-01-280000018498us-gaap:OtherIntangibleAssetsMember2023-01-2800000184982022-07-300000018498us-gaap:AdditionalPaidInCapitalMember2022-01-302022-04-300000018498gco:JohnstonAndMurphyGroupSegmentMember2022-05-012022-07-300000018498us-gaap:TreasuryStockCommonMember2023-01-280000018498us-gaap:OperatingSegmentsMember2023-01-292023-07-290000018498gco:JohnstonAndMurphyGroupSegmentMember2023-01-292023-07-290000018498us-gaap:FairValueInputsLevel3Member2023-07-290000018498us-gaap:AdditionalPaidInCapitalMember2022-04-300000018498us-gaap:AdditionalPaidInCapitalMember2023-04-290000018498gco:JourneysGroupSegmentMember2023-04-302023-07-290000018498us-gaap:OperatingSegmentsMember2022-05-012022-07-300000018498us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-01-2900000184982023-01-292023-07-2900000184982023-01-292023-04-290000018498us-gaap:OperatingSegmentsMembergco:GenescoBrandsSegmentMember2023-01-292023-07-290000018498us-gaap:CorporateNonSegmentMember2022-07-300000018498gco:JohnstonAndMurphyGroupSegmentMemberus-gaap:OperatingSegmentsMember2023-01-292023-07-290000018498country:CA2022-07-300000018498us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-05-012022-07-300000018498gco:JohnstonAndMurphyGroupSegmentMemberus-gaap:OperatingSegmentsMember2022-07-300000018498us-gaap:TreasuryStockCommonMember2023-04-290000018498us-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMembercountry:GB2023-01-292023-07-290000018498us-gaap:CorporateNonSegmentMember2023-04-302023-07-290000018498us-gaap:IntersegmentEliminationMembergco:JourneysGroupSegmentMember2023-04-302023-07-2900000184982023-07-290000018498us-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMembercountry:GB2022-01-302022-07-300000018498us-gaap:CommonStockMember2023-04-302023-07-290000018498gco:GenescoBrandsGroupMember2023-01-280000018498us-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMembersrt:NorthAmericaMember2023-04-302023-07-290000018498us-gaap:AdditionalPaidInCapitalMember2022-05-012022-07-3000000184982022-05-012022-07-300000018498us-gaap:TreasuryStockCommonMember2022-01-290000018498us-gaap:OperatingSegmentsMembergco:SchuhGroupSegmentMember2022-05-012022-07-300000018498gco:GenescoBrandsSegmentMemberus-gaap:OperatingSegmentsMember2022-05-012022-07-300000018498us-gaap:RetainedEarningsMember2022-01-290000018498us-gaap:OperatingSegmentsMembergco:SchuhGroupSegmentMember2023-01-292023-07-290000018498us-gaap:CommonStockMember2023-04-290000018498us-gaap:RetainedEarningsMember2022-07-300000018498us-gaap:CommonStockMember2023-01-2800000184982023-04-290000018498gco:JourneysGroupSegmentMember2022-01-302022-07-300000018498us-gaap:TreasuryStockCommonMember2022-07-300000018498us-gaap:OperatingSegmentsMembergco:JourneysGroupSegmentMember2022-05-012022-07-300000018498us-gaap:IntersegmentEliminationMember2023-01-292023-07-290000018498gco:JourneysGroupSegmentMemberus-gaap:IntersegmentEliminationMember2023-01-292023-07-290000018498us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-04-302023-07-290000018498us-gaap:PreferredStockMember2023-04-290000018498gco:JohnstonAndMurphyGroupSegmentMember2023-04-302023-07-290000018498us-gaap:OperatingSegmentsMembergco:JourneysGroupSegmentMember2023-04-302023-07-290000018498us-gaap:RetainedEarningsMember2023-01-280000018498us-gaap:IntersegmentEliminationMember2022-01-302022-07-300000018498us-gaap:PreferredStockMember2022-04-300000018498us-gaap:IntersegmentEliminationMembergco:SchuhGroupSegmentMember2022-05-012022-07-300000018498us-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMembercountry:GB2023-04-302023-07-290000018498gco:JohnstonAndMurphyGroupSegmentMemberus-gaap:OperatingSegmentsMember2022-05-012022-07-300000018498us-gaap:CommonStockMember2022-01-302022-04-300000018498us-gaap:CustomerListsMember2023-01-280000018498gco:RetailStoreAssetImpairmentsMembergco:JourneysGroupSegmentMember2022-01-302022-07-3000000184982022-01-290000018498us-gaap:OperatingSegmentsMembergco:JourneysGroupSegmentMember2023-07-290000018498us-gaap:CommonStockMember2022-04-300000018498gco:GenescoBrandsGroupMember2023-07-290000018498gco:UKRevolverBorrowingsMember2023-07-290000018498gco:WholesaleCostsOfDistributionMember2023-01-292023-07-290000018498us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-01-292023-04-290000018498country:GB2023-07-2900000184982023-08-250000018498gco:GenescoBrandsSegmentMemberus-gaap:IntersegmentEliminationMember2023-04-302023-07-290000018498us-gaap:TreasuryStockCommonMember2023-07-290000018498gco:JourneysGroupSegmentMember2023-07-290000018498us-gaap:PreferredStockMember2023-01-292023-04-290000018498us-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMembersrt:NorthAmericaMember2022-01-302022-07-300000018498gco:RetailStoreAssetImpairmentsMembergco:JourneysGroupSegmentMember2023-04-302023-07-290000018498us-gaap:IntersegmentEliminationMembergco:SchuhGroupSegmentMember2023-01-292023-07-290000018498us-gaap:OperatingSegmentsMembergco:JourneysGroupSegmentMember2022-07-3000000184982022-04-300000018498gco:JohnstonAndMurphyGroupSegmentMemberus-gaap:IntersegmentEliminationMember2022-05-012022-07-300000018498us-gaap:OperatingSegmentsMembergco:JohnstonAndMurphyGroupSegmentMember2023-04-302023-07-290000018498gco:GenescoBrandsSegmentMember2023-04-302023-07-290000018498gco:RetailStoreAssetImpairmentsMembergco:JourneysGroupSegmentMember2023-01-292023-07-290000018498gco:WholesaleCostsOfDistributionMember2023-04-302023-07-290000018498gco:RetailStoreAssetImpairmentsMembergco:SchuhGroupSegmentMember2022-01-302022-07-300000018498us-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMembersrt:NorthAmericaMember2022-05-012022-07-300000018498gco:GenescoBrandsSegmentMember2022-05-012022-07-300000018498gco:JohnstonAndMurphyGroupSegmentMember2022-01-302022-07-300000018498us-gaap:RetainedEarningsMember2023-07-290000018498gco:USRevolverBorrowingsMember2023-07-290000018498us-gaap:RetainedEarningsMember2023-01-292023-04-290000018498us-gaap:CorporateNonSegmentMember2023-01-292023-07-290000018498us-gaap:CorporateNonSegmentMember2022-01-302022-07-300000018498gco:USRevolverBorrowingsMember2023-01-280000018498gco:GenescoBrandsGroupMember2023-01-292023-07-290000018498us-gaap:CommonStockMember2023-01-292023-04-290000018498us-gaap:RetainedEarningsMember2023-04-302023-07-290000018498gco:UKRevolverBorrowingsMember2023-01-280000018498us-gaap:RetainedEarningsMember2022-04-300000018498us-gaap:RetainedEarningsMember2023-04-290000018498gco:GenescoBrandsSegmentMemberus-gaap:IntersegmentEliminationMember2022-01-302022-07-300000018498country:CA2023-07-290000018498us-gaap:OtherIntangibleAssetsMember2023-07-290000018498us-gaap:SubsequentEventMember2023-07-302023-09-060000018498gco:SchuhGroupSegmentMember2023-01-292023-07-290000018498us-gaap:OperatingSegmentsMembergco:JourneysGroupSegmentMember2022-01-302022-07-300000018498us-gaap:OperatingSegmentsMembergco:JohnstonAndMurphyGroupSegmentMember2023-07-290000018498us-gaap:OperatingSegmentsMember2022-01-302022-07-300000018498us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-07-300000018498country:GB2022-07-300000018498gco:JohnstonAndMurphyGroupSegmentMemberus-gaap:IntersegmentEliminationMember2023-01-292023-07-290000018498us-gaap:PreferredStockMember2023-01-280000018498us-gaap:AdditionalPaidInCapitalMember2023-01-292023-04-290000018498gco:SchuhGroupSegmentMember2022-01-302022-07-300000018498us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-07-290000018498gco:RetailStoreAssetImpairmentsMember2022-01-302022-07-300000018498us-gaap:PreferredStockMember2023-07-290000018498us-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMembersrt:NorthAmericaMember2023-01-292023-07-290000018498gco:GainOnTheTerminationOfThePensionPlanMember2022-01-302022-07-300000018498gco:GenescoBrandsSegmentMembergco:RetailStoreAssetImpairmentsMember2022-05-012022-07-300000018498us-gaap:OperatingSegmentsMembergco:SchuhGroupSegmentMember2022-07-300000018498us-gaap:OperatingSegmentsMembergco:JourneysGroupSegmentMember2023-01-292023-07-290000018498gco:SamsungCTAmericaIncorporationMember2023-07-290000018498us-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMembercountry:GB2022-05-012022-07-300000018498us-gaap:CommonStockMember2023-07-2900000184982022-01-302022-07-300000018498us-gaap:RetainedEarningsMember2022-05-012022-07-300000018498us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-01-302022-04-300000018498gco:GenescoBrandsSegmentMember2023-01-292023-07-290000018498gco:RetailOccupancyCostsMember2023-04-302023-07-290000018498us-gaap:RevolvingCreditFacilityMember2023-07-290000018498gco:JourneysGroupSegmentMember2023-01-292023-07-290000018498gco:JohnstonAndMurphyGroupSegmentMemberus-gaap:IntersegmentEliminationMember2023-04-302023-07-2900000184982023-01-280000018498gco:GenescoBrandsSegmentMemberus-gaap:IntersegmentEliminationMember2022-05-012022-07-300000018498us-gaap:CustomerListsMember2023-07-290000018498us-gaap:PreferredStockMember2022-07-300000018498gco:GenescoBrandsSegmentMemberus-gaap:OperatingSegmentsMember2022-07-300000018498us-gaap:OperatingSegmentsMembergco:SchuhGroupSegmentMember2022-01-302022-07-300000018498gco:JohnstonAndMurphyGroupSegmentMemberus-gaap:OperatingSegmentsMember2022-01-302022-07-300000018498gco:JourneysGroupSegmentMember2023-01-280000018498gco:WholesaleCostsOfDistributionMember2022-01-302022-07-300000018498gco:JourneysGroupSegmentMemberus-gaap:IntersegmentEliminationMember2022-01-302022-07-300000018498gco:GenescoBrandsSegmentMemberus-gaap:OperatingSegmentsMember2023-07-290000018498us-gaap:AdditionalPaidInCapitalMember2022-07-300000018498us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-04-300000018498gco:SchuhGroupSegmentMemberus-gaap:IntersegmentEliminationMember2023-04-302023-07-290000018498us-gaap:OperatingSegmentsMembergco:SchuhGroupSegmentMember2023-07-290000018498us-gaap:TrademarksMember2023-07-290000018498us-gaap:OperatingSegmentsMember2023-04-302023-07-290000018498gco:SchuhGroupSegmentMember2023-04-302023-07-290000018498gco:JourneysGroupSegmentMemberus-gaap:IntersegmentEliminationMember2022-05-012022-07-300000018498us-gaap:AdditionalPaidInCapitalMember2023-07-290000018498us-gaap:AdditionalPaidInCapitalMember2023-01-280000018498us-gaap:RevolvingCreditFacilityMembergco:USRevolverBorrowingsMember2023-07-290000018498gco:RetailOccupancyCostsMember2022-05-012022-07-300000018498us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-01-280000018498gco:RetailOccupancyCostsMember2023-01-292023-07-290000018498us-gaap:CommonStockMember2022-05-012022-07-300000018498us-gaap:CorporateNonSegmentMember2023-07-290000018498gco:GenescoBrandsSegmentMember2022-01-302022-07-300000018498gco:WholesaleCostsOfDistributionMember2022-05-012022-07-300000018498us-gaap:OperatingSegmentsMembergco:SchuhGroupSegmentMember2023-04-302023-07-290000018498us-gaap:PreferredStockMember2022-01-302022-04-300000018498us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-04-290000018498us-gaap:RevolvingCreditFacilityMembergco:GenescoCanadaUlcMember2023-07-290000018498gco:SchuhGroupSegmentMemberus-gaap:IntersegmentEliminationMember2022-01-302022-07-300000018498gco:JourneysGroupSegmentMember2022-05-012022-07-300000018498us-gaap:IntersegmentEliminationMember2022-05-012022-07-300000018498us-gaap:IntersegmentEliminationMember2023-04-302023-07-290000018498gco:GenescoBrandsSegmentMemberus-gaap:IntersegmentEliminationMember2023-01-292023-07-290000018498us-gaap:TreasuryStockCommonMember2022-04-300000018498gco:RetailOccupancyCostsMember2022-01-302022-07-300000018498us-gaap:RevolvingCreditFacilityMembergco:GenescoUkLimitedMember2023-07-2900000184982023-04-302023-07-2900000184982022-01-302022-04-300000018498us-gaap:PreferredStockMember2022-01-290000018498us-gaap:OperatingSegmentsMembergco:GenescoBrandsSegmentMember2023-04-302023-07-290000018498us-gaap:AdditionalPaidInCapitalMember2023-04-302023-07-290000018498us-gaap:OperatingSegmentsMembergco:GenescoBrandsSegmentMember2022-01-302022-07-300000018498us-gaap:CommonStockMember2022-01-290000018498gco:JohnstonAndMurphyGroupSegmentMemberus-gaap:IntersegmentEliminationMember2022-01-302022-07-300000018498us-gaap:CommonStockMember2022-07-300000018498us-gaap:FairValueInputsLevel1Member2023-07-290000018498gco:SchuhGroupSegmentMember2022-05-012022-07-300000018498gco:GenescoBrandsSegmentMembergco:RetailStoreAssetImpairmentsMember2022-01-302022-07-30xbrli:pureiso4217:USDxbrli:sharesxbrli:sharesiso4217:CADgco:Segmentgco:Storeiso4217:GBPiso4217:USD

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)

 

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarter Ended July 29, 2023

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the transition period from to

Commission File No. 1-3083

Genesco Inc.

(Exact name of registrant as specified in its charter)

Tennessee

62-0211340

(State or other jurisdiction of

incorporation or organization)

(I.R.S. Employer

Identification No.)

 

 

 

 

535 Marriott Drive

 

37214

Nashville,

Tennessee

 

(Zip Code)

(Address of principal executive offices)

 

 

 

Registrant's telephone number, including area code: (615) 367-7000

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common Stock, $1.00 par value

GCO

New York Stock Exchange

 

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such report), and (2) has been subject to such filing requirements for the past 90 days. Yes No

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes No

Indicate by check mark whether the registrant is a large accelerated filer; an accelerated filer; a non-accelerated filer; a smaller reporting company; or an emerging growth company. See definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act:

 

Large accelerated filer

Accelerated filer

Non-accelerated filer

Smaller reporting company

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act) Yes No

As of August 25, 2023, there were 11,505,683 shares of the registrant's common stock outstanding.

 


 

INDEX

 

Part I. Financial Information

Item 1. Financial Statements:

Condensed Consolidated Balance Sheets - July 29, 2023, January 28, 2023 and July 30, 2022

4

Condensed Consolidated Statements of Operations - Three and Six Months ended July 29, 2023 and July 30, 2022

5

Condensed Consolidated Statements of Comprehensive Income (Loss) - Three and Six Months ended July 29, 2023 and July 30, 2022

6

Condensed Consolidated Statements of Cash Flows - Six Months ended July 29, 2023 and July 30, 2022

7

Condensed Consolidated Statements of Equity - Three and Six Months ended July 29, 2023 and July 30, 2022

8

Notes to Condensed Consolidated Financial Statements

9

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations

16

Item 3. Quantitative and Qualitative Disclosures about Market Risk

24

Item 4. Controls and Procedures

24

Part II. Other Information

25

Item 1. Legal Proceedings

25

Item 1A. Risk Factors

25

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

25

Item 5. Other Information

25

Item 6. Exhibits

26

Signature

27

 

 

 

2


 

cautionary notice regarding forward-looking statements

Statements in this Quarterly Report on Form 10-Q include certain forward-looking statements, which include statements regarding our intent, belief or expectations and all statements other than those made solely with respect to historical fact. Actual results could differ materially from those reflected by the forward-looking statements in this Quarterly Report on Form 10-Q and a number of factors may adversely affect the forward-looking statements and our future results, liquidity, capital resources or prospects. These include, but are not limited to, adjustments to projections reflected in forward-looking statements, including those resulting from weakness in store and shopping mall traffic, restrictions on operations imposed by government entities and/or landlords, changes in public safety and health requirements and limitations on our ability to adequately staff and operate stores. Differences from expectations could also result from our ability to obtain from suppliers products that are in-demand on a timely basis and effectively manage disruptions in product supply or distribution, including disruptions as a result of pandemics or geopolitical events; the level of consumer spending on our merchandise and interest in our brands and in general; the level and timing of promotional activity necessary to maintain inventories at appropriate levels; our ability to pass on price increases to our customers; the timing and amount of any share repurchases by us; the imposition of tariffs on products imported by us or our vendors as well as the ability and costs to move production of products in response to tariffs; unfavorable trends in fuel costs, foreign exchange rates, foreign labor and material costs; a disruption in shipping or increase in cost of our imported products, and other factors affecting the cost of products; our dependence on third-party vendors and licensors for the products we sell; our ability to renew our license agreements; the effects of the British decision to exit the European Union, impacts of the Russia-Ukraine war, and other sources of market weakness in the U.K. and the Republic of Ireland; the effectiveness of our omni-channel initiatives; costs associated with changes in minimum wage and overtime requirements; wage pressure in the U.S. and the U.K.; labor shortages; the effects of inflation; the evolving regulatory landscape related to our use of social media; the establishment and protection of our intellectual property; weakness in the consumer economy and retail industry; competition and fashion trends in our markets, including trends with respect to the popularity of casual and dress footwear; any failure to increase sales at our existing stores, given our high fixed expense cost structure, and in our e-commerce businesses; risks related to the potential for terrorist events; store closures and effects on the business as a result of civil disturbances; changes in buying patterns by significant wholesale customers; changes in consumer preferences; our ability to continue to complete and integrate acquisitions; our ability to expand our business and diversify our product base; impairment of goodwill in connection with acquisitions; payment related risks that could increase our operating cost, expose us to fraud or theft, subject us to potential liability and disrupt our business; retained liabilities associated with divestitures of businesses including potential liabilities under leases as the prior tenant or as a guarantor of certain leases; and changes in the timing of holidays or in the onset of seasonal weather affecting period-to-period sales comparisons. Additional factors that could cause differences from expectations include our ability to secure allocations to refine product assortments to address consumer demand; the ability to renew leases in existing stores and control or lower occupancy costs, to open or close stores in the number and on the planned schedule, and to conduct required remodeling or refurbishment on schedule and at expected expense levels; our ability to realize anticipated cost savings, including rent savings; our ability to make our occupancy costs more variable, realize any anticipated tax benefits in both the amount and timeframe anticipated, and achieve expected digital gains and gain market share; deterioration in the performance of individual businesses or of our market value relative to our book value, resulting in impairments of fixed assets, operating lease right of use assets or intangible assets or other adverse financial consequences and the timing and amount of such impairments or other consequences; unexpected changes to the market for our shares or for the retail sector in general; our ability to meet our sustainability, stewardship, emission and diversity, equity and inclusion related ESG projections, goals and commitments; costs and reputational harm as a result of disruptions in our business or information technology systems either by security breaches and incidents or by potential problems associated with the implementation of new or upgraded systems, and the cost and outcome of litigation, investigations, disputes and environmental matters that involve us. For a full discussion of risk factors, see Item 1A, "Risk Factors".

Readers are cautioned not to place undue reliance on forward-looking statements as such statements speak only as of the date they were made and involve risks and uncertainties that could cause actual events or results to differ materially from the events or results described in the forward-looking statements. The most important factors which could cause our actual results to differ from our forward-looking statements are set forth in our description of risk factors in Item 1A contained in our Annual Report on Form 10-K for the fiscal year ended January 28, 2023, which should be read in conjunction with the forward-looking statements in this Quarterly Report on Form 10-Q. Forward-looking statements speak only as of the date they are made, and we do not undertake any obligation to update any forward-looking statement.

The events described in the forward-looking statements might not occur or might occur to a different extent or at a different time than we have described. As a result, our actual results may differ materially from the results contemplated by these forward-looking statements.

We maintain a website at www.genesco.com where investors and other interested parties may obtain, free of charge, press releases and other information as well as gain access to our periodic filings with the Securities and Exchange Commission (“SEC”). The information contained on this website should not be considered to be a part of this or any other report filed with or furnished to the SEC.

3


 

PART I - FINANCIAL INFORMATION

Item 1. Financial Statements (unaudited)

 

Genesco Inc. and Subsidiaries

Condensed Consolidated Balance Sheets

(In thousands, except share amounts)

 

Assets

 

July 29, 2023

 

 

January 28, 2023

 

 

July 30, 2022

 

Current Assets:

 

 

 

 

 

 

 

 

 

Cash and cash equivalents

 

$

37,416

 

 

$

47,990

 

 

$

44,939

 

Accounts receivable, net of allowances of $4,536 at July 29, 2023,

 

 

 

 

 

 

 

 

 

   $3,710 at January 28, 2023 and $5,335 at July 30, 2022

 

 

50,351

 

 

 

40,818

 

 

 

42,782

 

Inventories

 

 

491,118

 

 

 

458,017

 

 

 

507,236

 

Prepaids and other current assets

 

 

45,983

 

 

 

25,844

 

 

 

99,455

 

Total current assets

 

 

624,868

 

 

 

572,669

 

 

 

694,412

 

Property and equipment, net

 

 

244,090

 

 

 

233,733

 

 

 

220,742

 

Operating lease right of use assets

 

 

476,715

 

 

 

470,991

 

 

 

491,412

 

Non-current prepaid income taxes

 

 

55,028

 

 

 

54,111

 

 

 

 

Goodwill

 

 

9,717

 

 

 

38,123

 

 

 

38,523

 

Other intangibles

 

 

27,952

 

 

 

27,430

 

 

 

27,506

 

Deferred income taxes

 

 

30,623

 

 

 

28,563

 

 

 

4,519

 

Other noncurrent assets

 

 

25,766

 

 

 

30,806

 

 

 

22,606

 

Total Assets

 

 

1,494,759

 

 

 

1,456,426

 

 

 

1,499,720

 

Liabilities and Equity

 

 

 

 

 

 

 

 

 

Current Liabilities:

 

 

 

 

 

 

 

 

 

Accounts payable

 

 

166,504

 

 

 

144,998

 

 

 

226,779

 

Current portion - operating lease liabilities

 

 

137,369

 

 

 

134,458

 

 

 

135,571

 

Other accrued liabilities

 

 

78,707

 

 

 

81,327

 

 

 

80,266

 

Total current liabilities

 

 

382,580

 

 

 

360,783

 

 

 

442,616

 

Long-term debt

 

 

131,544

 

 

 

44,858

 

 

 

48,872

 

Long-term operating lease liabilities

 

 

403,413

 

 

 

401,113

 

 

 

413,416

 

Other long-term liabilities

 

 

44,203

 

 

 

42,706

 

 

 

34,283

 

Total liabilities

 

 

961,740

 

 

 

849,460

 

 

 

939,187

 

Commitments and contingent liabilities

 

 

 

 

 

 

 

 

 

Equity

 

 

 

 

 

 

 

 

 

Non-redeemable preferred stock

 

 

812

 

 

 

815

 

 

 

818

 

Common equity:

 

 

 

 

 

 

 

 

 

Common stock, $1 par value:

 

 

 

 

 

 

 

 

 

Authorized: 80,000,000 shares

 

 

 

 

 

 

 

 

 

 Issued common stock

 

 

11,996

 

 

 

13,089

 

 

 

13,557

 

Additional paid-in capital

 

 

313,019

 

 

 

305,260

 

 

 

298,010

 

Retained earnings

 

 

263,081

 

 

 

346,870

 

 

 

307,929

 

Accumulated other comprehensive loss

 

 

(38,032

)

 

 

(41,211

)

 

 

(41,924

)

Treasury shares, at cost (488,464 shares)

 

 

(17,857

)

 

 

(17,857

)

 

 

(17,857

)

Total equity

 

 

533,019

 

 

 

606,966

 

 

 

560,533

 

Total Liabilities and Equity

 

$

1,494,759

 

 

$

1,456,426

 

 

$

1,499,720

 

 

The accompanying Notes are an integral part of these Condensed Consolidated Financial Statements.

4


 

Genesco Inc. and Subsidiaries

Condensed Consolidated Statements of Operations

(In thousands, except per share amounts)

 

 

 

 

Three Months Ended

 

 

Six Months Ended

 

 

 

July 29, 2023

 

 

July 30, 2022

 

 

July 29, 2023

 

 

July 30, 2022

 

Net sales

 

$

523,027

 

 

$

535,332

 

 

$

1,006,359

 

 

$

1,056,080

 

Cost of sales

 

 

273,507

 

 

 

281,018

 

 

 

528,031

 

 

 

550,322

 

Gross margin

 

 

249,520

 

 

 

254,314

 

 

 

478,328

 

 

 

505,758

 

Selling and administrative expenses

 

 

259,520

 

 

 

245,103

 

 

 

511,017

 

 

 

488,584

 

Goodwill impairment

 

 

28,453

 

 

 

 

 

 

28,453

 

 

 

 

Asset impairments and other, net

 

 

174

 

 

 

129

 

 

 

482

 

 

 

(154

)

Operating income (loss)

 

 

(38,627

)

 

 

9,082

 

 

 

(61,624

)

 

 

17,328

 

Other components of net periodic benefit cost

 

 

148

 

 

 

50

 

 

 

240

 

 

 

148

 

Interest expense, net

 

 

2,383

 

 

 

405

 

 

 

4,034

 

 

 

702

 

Earnings (loss) from continuing operations before income taxes

 

 

(41,158

)

 

 

8,627

 

 

 

(65,898

)

 

 

16,478

 

Income tax expense (benefit)

 

 

(9,526

)

 

 

976

 

 

 

(15,391

)

 

 

3,858

 

Earnings (loss) from continuing operations

 

 

(31,632

)

 

 

7,651

 

 

 

(50,507

)

 

 

12,620

 

Loss from discontinued operations, net of tax

 

 

(33

)

 

 

(8

)

 

 

(48

)

 

 

(30

)

Net Earnings (Loss)

 

$

(31,665

)

 

$

7,643

 

 

$

(50,555

)

 

$

12,590

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic earnings (loss) per common share:

 

 

 

 

 

 

 

 

 

 

 

 

Continuing operations

 

$

(2.79

)

 

$

0.60

 

 

$

(4.36

)

 

$

0.98

 

Discontinued operations

 

 

0.00

 

 

 

0.00

 

 

 

(0.01

)

 

 

0.00

 

Net earnings (loss)

 

$

(2.79

)

 

$

0.60

 

 

$

(4.37

)

 

$

0.98

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Diluted earnings (loss) per common share:

 

 

 

 

 

 

 

 

 

 

 

 

Continuing operations

 

$

(2.79

)

 

$

0.59

 

 

$

(4.36

)

 

$

0.96

 

Discontinued operations

 

 

0.00

 

 

 

0.00

 

 

 

(0.01

)

 

 

(0.01

)

Net earnings (loss)

 

$

(2.79

)

 

$

0.59

 

 

$

(4.37

)

 

$

0.95

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average shares outstanding:

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

 

11,344

 

 

 

12,813

 

 

 

11,581

 

 

 

12,887

 

Diluted

 

 

11,344

 

 

 

13,009

 

 

 

11,581

 

 

 

13,189

 

 

The accompanying Notes are an integral part of these Condensed Consolidated Financial Statements.

5


 

Genesco Inc. and Subsidiaries

Condensed Consolidated Statements of Comprehensive Income (Loss)

(In thousands)

 

 

 

 

Three Months Ended

 

 

Six Months Ended

 

 

 

July 29, 2023

 

 

July 30, 2022

 

 

July 29, 2023

 

 

July 30, 2022

 

Net earnings (loss)

 

$

(31,665

)

 

$

7,643

 

 

$

(50,555

)

 

$

12,590

 

Other comprehensive income (loss):

 

 

 

 

 

 

 

 

 

 

 

 

Postretirement liability adjustments, net of tax

 

 

62

 

 

 

13

 

 

 

91

 

 

 

63

 

Foreign currency translation adjustments

 

 

2,643

 

 

 

(1,712

)

 

 

3,088

 

 

 

(5,579

)

Total other comprehensive income (loss)

 

 

2,705

 

 

 

(1,699

)

 

 

3,179

 

 

 

(5,516

)

Comprehensive Income (Loss)

 

$

(28,960

)

 

$

5,944

 

 

$

(47,376

)

 

$

7,074

 

 

The accompanying Notes are an integral part of these Condensed Consolidated Financial Statements.

6


 

 

Genesco Inc. and Subsidiaries

Condensed Consolidated Statements of Cash Flows

(In thousands)

 

 

 

Six Months Ended

 

 

 

July 29, 2023

 

 

July 30, 2022

 

CASH FLOWS FROM OPERATING ACTIVITIES:

 

 

 

 

 

 

Net earnings (loss)

 

$

(50,555

)

 

$

12,590

 

Adjustments to reconcile net earnings (loss) to net cash used in

 

 

 

 

 

 

operating activities:

 

 

 

 

 

 

Depreciation and amortization

 

 

23,119

 

 

 

21,229

 

Deferred income taxes

 

 

(1,576

)

 

 

(3,075

)

Goodwill impairment

 

 

28,453

 

 

 

 

Impairment of long-lived assets

 

 

482

 

 

 

542

 

Share-based compensation expense

 

 

7,925

 

 

 

6,788

 

Other

 

 

686

 

 

 

413

 

Changes in working capital and other assets and liabilities:

 

 

 

 

 

 

Accounts receivable

 

 

(9,623

)

 

 

(3,753

)

Inventories

 

 

(30,237

)

 

 

(234,018

)

Prepaids and other current assets

 

 

(19,901

)

 

 

(28,510

)

Accounts payable

 

 

23,394

 

 

 

71,258

 

Other accrued liabilities

 

 

(1,076

)

 

 

(46,638

)

Other assets and liabilities

 

 

3,774

 

 

 

(21,037

)

Net cash used in operating activities

 

 

(25,135

)

 

 

(224,211

)

CASH FLOWS FROM INVESTING ACTIVITIES:

 

 

 

 

 

 

Capital expenditures

 

 

(35,298

)

 

 

(29,005

)

Proceeds from asset sales

 

 

87

 

 

 

 

Net cash used in investing activities

 

 

(35,211

)

 

 

(29,005

)

CASH FLOWS FROM FINANCING ACTIVITIES:

 

 

 

 

 

 

Borrowings under revolving credit facility

 

 

244,452

 

 

 

62,000

 

Payments on revolving credit facility

 

 

(158,405

)

 

 

(27,375

)

Shares repurchased related to share repurchase plan

 

 

(32,027

)

 

 

(56,329

)

Shares repurchased related to taxes for share-based awards

 

 

(2,205

)

 

 

(3,875

)

Change in overdraft balances

 

 

(2,707

)

 

 

4,841

 

Other

 

 

 

 

 

2

 

Net cash provided by (used in) financing activities

 

 

49,108

 

 

 

(20,736

)

Effect of foreign exchange rate fluctuations on cash

 

 

664

 

 

 

(1,634

)

Net decrease in cash and cash equivalents

 

 

(10,574

)

 

 

(275,586

)

Cash and cash equivalents at beginning of period

 

 

47,990

 

 

 

320,525

 

Cash and cash equivalents at end of period

 

$

37,416

 

 

$

44,939

 

Supplemental information:

 

 

 

 

 

 

Interest paid

 

$

3,380

 

 

$

504

 

Income taxes paid

 

 

3,813

 

 

 

25,718

 

Cash paid for amounts included in measurement of operating lease liabilities

 

 

86,747

 

 

 

101,687

 

Operating lease assets obtained in exchange for new operating lease liabilities

 

 

84,643

 

 

 

41,137

 

 

The accompanying Notes are an integral part of these Condensed Consolidated Financial Statements.

7


 

Genesco Inc. and Subsidiaries

Condensed Consolidated Statements of Equity

(In thousands)

 

 

Non-
Redeemable
Preferred
Stock

 

Common
Stock

 

Additional
Paid-In
Capital

 

Retained
Earnings

 

Accumulated
Other
Comprehensive
Loss

 

Treasury
Shares

 

Total
Equity

 

Balance January 29, 2022

$

827

 

$

14,256

 

$

291,444

 

$

350,206

 

$

(36,408

)

$

(17,857

)

$

602,468

 

Net earnings

 

 

 

 

 

 

 

4,947

 

 

 

 

 

 

4,947

 

Other comprehensive loss

 

 

 

 

 

 

 

 

 

(3,817

)

 

 

 

(3,817

)

Share-based compensation expense

 

 

 

 

 

3,239

 

 

 

 

 

 

 

 

3,239

 

Restricted stock issuance

 

 

 

78

 

 

(78

)

 

 

 

 

 

 

 

 

Shares repurchased

 

 

 

(104

)

 

 

 

(6,396

)

 

 

 

 

 

(6,500

)

Other

 

(9

)

 

(13

)

 

23

 

 

 

 

 

 

 

 

1

 

 Balance April 30, 2022

 

818

 

 

14,217

 

 

294,628

 

 

348,757

 

 

(40,225

)

 

(17,857

)

 

600,338

 

Net earnings

 

 

 

 

 

 

 

7,643

 

 

 

 

 

 

7,643

 

Other comprehensive loss